The European Medicines Agency
(EMA) is warning healthcare
professionals across the EU to
be aware that vials of the cancer
medicine Herceptin (trastuzumab)
have been tampered with and
re-introduced into supply chains in
some countries.
The vials were thought to have
been stolen from Italy and reintroduced
under false credentials,
with warning signs including batch
numbers and expiry dates that
do not match, and liquid in some
of the vials when Herceptin is a
powder.
None of the falsified product had
been identified at hospital level and
no harm had come to patients, the
EMA reported.
Authorities were investigating, the
EMA said.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Apr 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.